Pfizer braces for work stoppage after announcing it will switch the pensions of Irish holdouts

Pfizer Little Island plant Ireland
Workers at Pfizer's Little Island plant in Ireland are expected to participate in a work stoppage this month in protest of pension changes the company is making. (Pfizer)

After five years of negotiations, Pfizer has decided it’s time to move employees at plants in Ireland to the same pension plans that the rest of the company’s employees have. That decision comes despite the threat of a work stoppage.

In a statement today, Pfizer said it will move the roughly 900 employees from defined benefit pension plans to defined contribution plans where employees participate in funding their own retirement savings. The April 1 move includes additional payments to employees by Pfizer as recommended by Ireland’s Labour Court.  

“Pfizer is disappointed that the outcome of the union ballots support industrial action, which is disproportionate. Pfizer has accepted the Labour Court recommendation which includes enhanced terms and transitional arrangements.”

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

The workers last month rejected the proposal of Pfizer and an Irish Labour Court and approved work actions for this month. Most of the holdouts work at Pfizer plants in Ringaskiddy and Little Island in County Cork, with the rest employed in shared services and commercial operations in Dublin.

After the rejection, the union said it plans a 24-hour work stoppage in the Ringaskiddy facility on Feb. 15 followed by a 24-hour work stoppage in both plants on Feb. 18, the Irish Examiner reported.

RELATED: Pfizer workers in Ireland fight to keep old school pensions

As part of the enhanced terms, workers over the age of 50 will be allowed to keep their current pension plans until they retire and the rest of workers between the ages of 35 and 50 have them phased out over three, five and seven years. In addition, the court recommended that an initial lump sum of €10,000 be paid to the workers to “reflect that future pension arrangement will be contributory for members,” stipulations that Pfizer also accepted.

Pfizer has pointed out that its cost to fund its so-called defined benefit pensions, in which employees make no contribution, have gone up 1,000% since 2009 “and these costs are affecting the competitiveness of Irish operations.” It said that its remaining 1,400 workers in the country have already made the change over to direct contribution plans.

Suggested Articles

Alcon has many "mass and structural advantages" over "distant" follower Bausch, which spends a lot less on R&D, says one analyst.

The judge in a multistate case against opioid makers scoffed at their request for more time to review an estimate that they owe $480 billion in damages.

Indian drugmakers pick up U.S. generics scripts; Chi-Med files for Hong Kong listing; an explosion at a Qilu Pharma subsidiary kills 10.